The National Cancer Institute (NCI) is offering this grant to establish a Coordinating Center for the Canine Cancer Immunotherapy Network (K9CIN), a crucial initiative involving the NCI Comparative Oncology Program. This grant is for facilitating a collaborative network focused on conducting immunotherapy clinical trials in pet dogs with spontaneous tumors, coupled with essential laboratory correlative studies. The Coordinating Center will provide comprehensive administrative and statistical support, ensuring the standardization of clinical protocols and correlative assays. Its responsibilities include overseeing the implementation of clinical studies, managing patient accrual, and facilitating the efficient sharing of research agents, specimens, and data. Ultimately, this effort will harmonize clinical data for submission to the Integrated Canine Data Commons, significantly advancing canine cancer immunotherapy research.
Opportunity ID: 334941
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-051 |
| Funding Opportunity Title: | Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 27, 2021 |
| Last Updated Date: | Jul 27, 2021 |
| Original Closing Date for Applications: | Sep 27, 2021 |
| Current Closing Date for Applications: | Sep 27, 2021 |
| Archive Date: | Nov 02, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $375,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Small businesses City or township governments Special district governments Private institutions of higher education State governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support a coordinating center to facilitate coordination across the Canine Cancer Immunotherapy Network (K9CIN; see U01 awards supported under companion RFA-CA-21-050) that will conduct immunotherapy clinical trials in pet dogs with spontaneous tumors and perform laboratory correlative studies associated with the clinical trials. The network will include a representative from the NCI Comparative Oncology Program (COP) of the NCI’s Center for Cancer Research as an integral component. The awardee will contribute to the administration of a steering committee of required expertise–both inside and outside the U01 network, including the PD/PIs of the U01s, representatives of the COP, and the NCI Project Collaborators –to ensure that the goals of the network are accomplished. The Coordinating Center will have several responsibilities, including, but not limited to providing administrative support to the K9CIN: development and standardization of clinical protocols and correlative assays; implementation of clinical studies in immunotherapy and combination agents including accrual to the trials; providing statistical support; facilitating sharing of agents, specimens, and data; harmonization of clinical data; and submission of clinical and correlative data to the Integrated Canine Data Commons. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-051.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268315 | Aug 27, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334941 RR_SF424_2_0-2.0.pdf
334941 PHS398_CoverPageSupplement_5_0-5.0.pdf
334941 RR_OtherProjectInfo_1_4-1.4.pdf
334941 PerformanceSite_2_0-2.0.pdf
334941 RR_KeyPersonExpanded_2_0-2.0.pdf
334941 RR_Budget_1_4-1.4.pdf
334941 PHS398_ResearchPlan_4_0-4.0.pdf
334941 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334941 RR_SubawardBudget30_1_4-1.4.pdf
334941 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
